Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Eric R. Fenstad"'
Autor:
Garvan C. Kane, Rachel J. Le, Robert P. Frantz, Eric R. Fenstad, Michael D. McGoon, Carolyn M. Larsen, Robert B. McCully
Publikováno v:
Heart & Lung. 48:34-38
Background Pulmonary arterial hypertension (PAH) is a progressive vascular disorder with a high mortality. Clinical experience and small case series suggest thrombocytopenia may be frequent in this population and associated with a poor prognosis. We
Autor:
Sorin V. Pislaru, Chalailak Assawakawintip, Garvan C. Kane, Eric R. Fenstad, Annop Lekhakul, Jeremy J. Thaden, Larry J. Sinak
Publikováno v:
The American Journal of Cardiology. 122:1091-1094
Malignancy is a common cause of pericardial effusions. The findings, immediate safety and longer-term outcomes of pericardiocentesis are less well defined. We reviewed the cases of all patients with malignancy that underwent pericardiocentesis at our
Autor:
Assefa M. Ayalew, Larry J. Sinak, Eric R. Fenstad, Sorin V. Pislaru, Garvan C. Kane, Jae K. Oh, Vuyisile T. Nkomo, Jeremy J. Thaden, Joseph F. Maalouf, Annop Lekhakul, Chalailak Assawakawintip
Publikováno v:
Mayo Clinic Proceedings. 93:1086-1095
Objective As invasive cardiovascular care has become increasingly complex, cardiac perforation leading to hemopericardium is a progressively prevalent complication. We sought to assess the frequency, etiology, and outcomes of hemorrhagic pericardial
Autor:
Peter J. Stokman, Timothy G. Dirks, Eric R. Fenstad, Andrew W. Shafer, Shawna Reed, Brynn E. Stenehjem
Publikováno v:
Journal of the Minneapolis Heart Institute Foundation. 1:79-83
Chronic thromboembolic pulmonary hypertension is 1 of 5 classifications of pulmonary hypertension. A patient with progressive dyspnea on exertion for the past 2 years underwent diagnostic ...
Autor:
Garvan C. Kane, Karen L. Swanson, Michael J. Krowka, Robert P. Frantz, Melissa A. Lyle, Michael D. McGoon, Eric R. Fenstad
Publikováno v:
Chest. 149:362-371
Background A subset of patients with hereditary hemorrhagic telangiectasia (HHT) develops pulmonary hypertension (PH) by mechanisms including pulmonary arterial hypertension, high flow, and elevated pulmonary arterial wedge pressure (PAWP). We aimed
Publikováno v:
Advances in Pulmonary Hypertension. 15:26-31
Summary: Pulmonary hypertension (PH) can be associated with a high level of symptom burden from the disease as well as its treatment. Involvement of palliative care (PC) services may help facilitate discussion regarding goals of care, prognostic plan
Autor:
James F. Glockner, Philip A. Araoz, Richard L. Ehman, Bogdan Dzyubak, Eric E. Williamson, Phillip M. Young, Eric R. Fenstad, Jae K. Oh, Nandan S. Anavekar, Sudhakar K. Venkatesh, Michael D. Leise
Publikováno v:
Journal of Magnetic Resonance Imaging. 44:81-88
Purpose To evaluate with magnetic resonance elastography (MRE) whether patients with constrictive pericarditis (CP) have increased hepatic stiffness. CP results in reduced pericardial compliance, ventricular interdependence, and right heart failure.
Publikováno v:
Journal of the American College of Cardiology. 75:2092
Pulmonary hypertension (PH) with aortic stenosis impacts 1- and 2-year survival following transcatheter aortic valve replacement (TAVR). Most PH patients who undergo TAVR normalize right ventricular systolic pressure (RVSP), yet a subset have residua
Publikováno v:
Acute Cardiac Care. 18:25-27
Left ventricular non-compaction cardiomyopathy is a rare congenital cardiomyopathy, which usually presents early in life but may also manifest into adulthood. We present the case of an elderly woman with left ventricular non-compaction cardiomyopathy
Autor:
Eric R. Fenstad, Robert P. Frantz, Rachel J. Le, Jae K. Oh, Hilal Maradit-Kremers, Assefa M. Ayalew, Michael D. McGoon, Naser M. Ammash, Robert B. McCully, Garvan C. Kane, Hector R. Villarraga, Lawrence J. Sinak
Publikováno v:
Chest. 144:1530-1538
Background The presence and size of a pericardial effusion in pulmonary arterial hypertension (PAH) and its association with outcome is unclear. Methods In this single-center cohort study of 577 patients with group 1 PAH seen between January 1, 1995,